Larvol Delta - VIRTUAL-Six-Month-Findings-from-a-Phase-12-Clinical-Study-of-Subretinal-Gene-Therapy-Drug-AGTC501-for-XLinked-Retinitis-Pigmentosa-Show-Clinically-Meaningful-Improvement-in-Macular-Sensitivity

rAAV2tYF-CB-hRS1 - AGTC

https://www.arvo.org/globalassets/annual-meeting/arvo-2021/arvo-2021-abstracts.pdf

Y. Liu; D. Sun; S. Khattak; J. Cao; R. Romano

May 13, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next